Pfizer-BioNTech COVID-19 vaccine trial

URI: https://gptkb.org/entity/Pfizer-BioNTech_COVID-19_vaccine_trial
GPTKB entity
Statements (43)
Predicate Object
gptkbp:instanceOf gptkb:clinical_trial
gptkbp:adverseEvents fever
fatigue
headache
joint pain
muscle pain
chills
pain at injection site
mild to moderate
gptkbp:ageRange 16 years and older
gptkbp:clinicalTrials.gov_Identifier gptkb:NCT04368728
gptkbp:doseInterval 21 days
gptkbp:doubleBlind true
gptkbp:effect about 95%
gptkbp:endPoint symptomatic COVID-19 infection
https://www.w3.org/2000/01/rdf-schema#label Pfizer-BioNTech COVID-19 vaccine trial
gptkbp:location gptkb:Argentina
gptkb:Brazil
gptkb:Germany
gptkb:South_Africa
gptkb:Turkey
gptkb:United_States
gptkbp:numberOfDoses 2
gptkbp:participants over 43,000
gptkbp:period Phase 1
Phase 2
Phase 3
gptkbp:placeboControlled true
gptkbp:publicationDate December 2020
gptkbp:publishedIn gptkb:The_New_England_Journal_of_Medicine
gptkbp:randomized true
gptkbp:regulatorySubmission gptkb:FDA
gptkb:EMA
gptkb:MHRA
gptkbp:result prevention of COVID-19
vaccine authorized for emergency use
gptkbp:sponsor gptkb:Pfizer
gptkb:BioNTech
gptkbp:startDate 2020
gptkbp:studiedBy gptkb:BNT162b2
gptkbp:vaccineType vaccine
gptkbp:bfsParent gptkb:Ventavia_Research_Group
gptkbp:bfsLayer 7